EIF2AK2 anticorps (AA 11-42)
Aperçu rapide pour EIF2AK2 anticorps (AA 11-42) (ABIN3030884)
Antigène
Voir toutes EIF2AK2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 11-42
-
Fonction
- PKR Antibody
-
Purification
- Purified
-
Immunogène
- A portion of amino acids 11-42 from the human protein was used as the immunogen for this PKR antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the PKR antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the PKR antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))
-
Autre désignation
- PKR
-
Sujet
- Interferon-induced, double-stranded RNA-activated protein kinase (PRKR/PKR) is a serine-threonine kinase. Activation by dsRNAs leads to autophosphorylation of PKR and allows the kinase to phosphorylate its natural substrate, the alpha subunit of eukaryotic protein synthesis initiation factor-2 (EIF2-alpha), leading to the inhibition of protein synthesis. PRKR, which is involved in TLR signaling and mediates apoptosis in fibroblasts in response to viral infection and inflammatory cytokines, activates IKK and NFKB, thereby suppressing apoptosis. Apoptosis induced by live pathogenic gram-positive and gram-negative bacteria requirs both TLR4 and PKR, possibly representing a major mechanism for pathogenic bacteria that use specific virulence factors to avoid detection and destruction by the innate immune system.
-
UniProt
- P19525
-
Pathways
- Réparation de l'ADN, ER-Nucleus Signaling, Hepatitis C
Antigène
-